Mujadala M. Abdul-Majid
FDA investigator
Appears on 1 document from 2014, mostly at sites in West Virginia. Most often cites design and construction features (21 CFR 211.42).
- 1
- Documents on file
- 8.0
- Observations per 483
- 2014
- First seen
- 2014
- Most recent
What they cite most
From 8 observations- 21 CFR 211.42Design and construction features3
- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.137Expiration dating1
- 21 CFR 211.166Stability testing1
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures1
Activity by year
2014: 1
Where
West Virginia 1
Often inspects with
Is Mujadala M. Abdul-Majid coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2014-12-12 | 483 PharmaLogic CSP, Inc.Dec 12, 2014 · Bridgep ort, West Virginia | Bridgep ort, West Virginia | 8 |
About this profile
What does Mujadala M. Abdul-Majid inspect?
Mujadala M. Abdul-Majid appears on 1 document on file covering 1 site, mostly in West Virginia.
What do they cite most often?
21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.137.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Mujadala M. Abdul-Majid is dated Dec 12, 2014.